Christine Zedelmayer
Chief Operating Officer of Equillium, Inc.
Zedelmayer brings more than 25 years of experience leading operations, program management, business development, and investor relations for life science companies to the KGI board. She has served as Chief Operating Officer of Equillium, Inc., a public, clinical-stage biotech company based in La Jolla focused on developing medicines for autoimmune and immuno-inflammatory disorders, since 2017. Prior to Equillium, Inc., Zedelmayer was owner, CEO, and principal consultant of Centerra Consulting, LLC, in San Diego.
Zedelmayer earned her bachelor's degree in electrical engineering from San Diego State University and an MBA from California Lutheran University.